Athersys Inc (ATHX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

3201 CARNEGIE AVENUE CLEVELAND, OH 44115-2634

Athersys is an international biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem® cell therapy product, a patented, adult-derived 'off-the-shelf' stem cell product, initially for disease indications in the neurological, inflammatory and immune, cardiovascular, and other critical care indications and has several ongoing clinical trials evaluating this potential regenerative medicine product. Athersys has forged strategic partnerships and a broad network of collaborations to further advance the MultiStem cell therapy toward commercialization.

Data as of 2021-10-09 09:03:37 -0400
Market Cap294.132 Million Shares Outstanding226.255 Million Avg 30-day Volume1.008 Million
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-3.44 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.28158 52-week High/Low3.03 / 1.3 Next Earnings Date2021-11-09 Price to Cash FLow (P/CF) -15.408
Data provided by IEX Cloud
View SEC Filings from ATHX instead.

View recent insider trading info

Funds Holding ATHX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ATHX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

56.1 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LEHMANN WILLIAM JR INTERIM CEO, PRESIDENT, COO

  • Officer
471,287 2021-09-17 6

MACLEOD IVOR CHIEF FINANCIAL OFFICER

  • Officer
131,583 2021-09-17 3

HARRINGTON JOHN J EXEC VICE PRES AND CSO

  • Officer
  • Director
730,960 2021-09-15 8

WYSZOMIERSKI JACK L

  • Director
50,000 2021-06-15 1

RANDALL LORIN

  • Director
50,000 2021-06-15 1

WASMAN JANE

  • Director
50,000 2021-06-15 3

KOLA ISMAIL

  • Director
50,000 2021-06-15 2

SHAH BAIJU R.

  • Director
50,000 2021-06-15 3

KALIN KATHERINE BACH

  • Director
50,000 2021-06-15 3

CAMPBELL LAURA K SENIOR VICE PRES FINANCE

  • Officer
817,384 2021-03-16 3

TRAUB KENNETH H

  • Director
0 2021-02-17 2

VAN BOKKELEN GIL CHAIRMAN AND CEO

  • Officer
  • Director
1,680,920 2020-12-17 1

BABISS LEE

  • Director
0 2020-06-18 0

KAGIMOTO TADAHISA

  • Director
  • 10% Owner
12,000,000 2018-06-18 0

HEALIOS K.K.

  • 10% Owner
12,000,000 2018-06-06 0

DAVIS JORDAN

  • Director
0 2017-06-07 0

DEANS ROBERT J EXECUTIVE VICE PRESIDENT

  • Officer
426,639 2015-06-24 0

MILNE GEORGE M JR

  • Director
0 2011-06-16 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP III LLC

ISALY SAMUEL D

  • 10% Owner
15,250,600 2011-04-11 0

LOOP FLOYD D MD

  • Director
0 2010-06-10 0

SHEFFERY MICHAEL B

  • Director
  • 10% Owner
0 2010-06-10 0

ORBIMED ADVISORS LLC

ISALY SAMUEL D

  • Director
  • 10% Owner
1,805,100 2009-12-28 0

MULLIGAN WILLIAM C

  • Director
0 2009-06-09 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

LEHMANN WILLIAM JR - Officer INTERIM CEO, PRESIDENT, COO

2021-09-21 17:01:38 -0400 2021-09-20 S 30,000 $1.41 d 471,287 direct 1.4184 -3.5461 1.4184 2 -3.5461 6

HARRINGTON JOHN J - Director - Officer EXEC VICE PRES AND CSO

2021-09-17 19:58:10 -0400 2021-09-17 F 11,981 $1.47 d 730,960 direct 2.1583 0.7194 2.8777 4 0.0 1

LEHMANN WILLIAM JR - Officer INTERIM CEO, PRESIDENT, COO

2021-09-21 17:01:38 -0400 2021-09-17 F 8,234 $1.47 d 501,287 direct 1.4184 -3.5461 1.4184 2 -3.5461 6

MACLEOD IVOR - Officer CHIEF FINANCIAL OFFICER

2021-09-21 16:55:02 -0400 2021-09-17 F 1,750 $1.47 d 131,583 direct 1.4184 -3.5461 1.4184 2 -3.5461 6

HARRINGTON JOHN J - Director - Officer EXEC VICE PRES AND CSO

2021-09-17 19:58:10 -0400 2021-09-16 S 5,000 $1.45 d 742,941 direct 2.1583 0.7194 2.8777 4 0.0 1

HARRINGTON JOHN J - Director - Officer EXEC VICE PRES AND CSO

2021-09-17 19:58:10 -0400 2021-09-15 S 21,050 $1.46 d 747,941 direct 2.1583 0.7194 2.8777 4 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ATHERSYS INC ATHX 2021-10-15 22:15:04 UTC -0.8387 0.9087 3700000
ATHERSYS INC ATHX 2021-10-15 21:45:03 UTC -0.8387 0.9087 3700000
ATHERSYS INC ATHX 2021-10-15 21:15:03 UTC -0.8387 0.9087 3700000
ATHERSYS INC ATHX 2021-10-15 20:45:03 UTC -0.8387 0.9087 3700000
ATHERSYS INC ATHX 2021-10-15 20:15:03 UTC -0.8387 0.9087 3700000
ATHERSYS INC ATHX 2021-10-15 19:45:03 UTC -0.8387 0.9087 3700000
ATHERSYS INC ATHX 2021-10-15 19:15:04 UTC -0.8387 0.9087 3700000
ATHERSYS INC ATHX 2021-10-15 18:45:03 UTC -0.8416 0.9116 3700000
ATHERSYS INC ATHX 2021-10-15 18:15:03 UTC -0.8416 0.9116 3700000
ATHERSYS INC ATHX 2021-10-15 17:45:03 UTC -0.8416 0.9116 3700000
ATHERSYS INC ATHX 2021-10-15 17:15:03 UTC -0.8416 0.9116 3700000
ATHERSYS INC ATHX 2021-10-15 16:45:03 UTC -0.8416 0.9116 3700000
ATHERSYS INC ATHX 2021-10-15 16:15:03 UTC -0.8416 0.9116 3700000
ATHERSYS INC ATHX 2021-10-15 15:45:03 UTC -0.8416 0.9116 3700000
ATHERSYS INC ATHX 2021-10-15 15:15:03 UTC -0.8416 0.9116 3700000
ATHERSYS INC ATHX 2021-10-15 14:45:02 UTC -0.8151 0.8851 3700000
ATHERSYS INC ATHX 2021-10-15 14:15:03 UTC -0.8151 0.8851 3700000
ATHERSYS INC ATHX 2021-10-15 13:45:03 UTC -0.8151 0.8851 3700000
ATHERSYS INC ATHX 2021-10-15 13:15:03 UTC -0.8151 0.8851 3700000
ATHERSYS INC ATHX 2021-10-15 12:45:03 UTC -0.8151 0.8851 3700000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund ATHX -400.0 shares, $-576.0 2021-06-30 N-PORT

Elevate your investments